Individual cells respond to electrical signal

Dec 05, 2012

Researchers at the Department of Molecular Nanofabrication (part of the University of Twente's MESA+ Institute for Nanotechnology) have published their preliminary results in a prominent article in Angewandte Chemie. This work was carried out in the context of a European Research Council (ERC) project that was awarded in 2010 for a period of five years. The leader of the research team, Dr Pascal Jonkheijm, explains that "Our approach to coupling chemistry at protein level worked so well that we immediately went one step further. Now we can use supramolecules to electrically switch the behaviour of individual cells. This occurs under the same physiological conditions as those found in the body."

The latter finding is enormously important in terms of the highly specific and local administration of medication, at the molecular level. The trick is to bind ligands (antibodies) to . The success or failure of this approach is not simply a question of pure chemistry. It also depends on the, occasionally indefinable, "watery" conditions around the cell.

Wound

Dr Jonkheijm and the publishers of are excited by this new method, because it enables ligands to be presented "dynamically". An external electric field determines whether the cells bind to the ligands or unbind from them. The experiments carried out by these University of Twente researchers involved an order of magnitude of 0.4 volts. On a specially prepared surface, a "wound" inflicted on a cell-covered substrate healed significantly faster than it would under normal conditions in a healthy body.

The star of the show in this approach is a pumpkin-shaped that can accommodate two linear "guest molecules" in its "skeleton". One binds to a specially prepared , the other stretches its "feelers" out to a specific (diseased) body cell. The links appear to be reversible. Reversing the causes cells to bind or to unbind. In some cases it is possible to partially bind the cells.

Towards applications

Pascal Jonkheijm feels that "This research opens the way to studies of fundamental aspects of cell biology. At the same time, however, together with researchers at the University of Twente's MIRA Institute for Biomedical Technology and Technical Medicine and our partners in the BioMedical Materials programme, we are also considering possible applications. We want to attach the molecules to platforms carrying various , which we can then present dynamically in terms of time and place. In this way, we can force or "trigger" target cells to bind under the most natural conditions. In the case of regeneration, for example, natural factors often play a decisive part. For instance, in the worst case, any infections that develop during treatment can lead to rejection. In such situations, the ability to control events at the cellular level is an important tool."

The researchers (Dr Qi An and PhD students Jenny Brinkmann and Sven Krabbenborg) also want to see whether this method might be useful for detecting specific cells, using "cell fingerprints".

Explore further: Jumping hurdles in the RNA world

More information: "Supramolecularly Programmed Subcellular Release of Cells by Electrochemical Stimulus", Qi An, Jenny Brinkmann, Sven Krabbenborg, Jan de Boer and Pascal Jonkheijm, Angewandte Chemie

add to favorites email to friend print save as pdf

Related Stories

Capturing living cells in micro pyramids

Nov 22, 2012

A field full of pyramids, but on a micro scale. Each of the pyramids hides a living cell. Thanks to 3D micro- and nano scale fabrication, promising new applications can be found. One of them is applying the ...

Scientists identify new cellular receptor for HIV

Feb 10, 2008

A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute ...

How Does the Antitumor Drug Get to the Cell Nucleus?

Oct 30, 2007

Platinum complexes such as the well-known cisplatin are powerful antitumor medications. They cross the cell membrane and reach the nucleus, where they attach to DNA and stop cell growth. But how does cisplatin get to the ...

A better delivery system for chemotherapy drugs

May 30, 2012

Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price — many healthy cells essential for body functions are also targeted ...

Recommended for you

Molecules that came in handy for first life on Earth

37 minutes ago

For the first time, chemists have successfully produced amino acid-like molecules that all have the same 'handedness', from simple building blocks and in a single test tube. Could this be how life started. ...

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

New computer model sets new precedent in drug discovery

Nov 18, 2014

A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has ...

Finding new ways to make drugs

Nov 18, 2014

Chemists have developed a revolutionary new way to manufacture natural chemicals and used it to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.